Code intelligence

LCD-DL40433 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code LCD-DL40433.

Elevated code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Elevated

Critical

High

100%

Routine

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

Proposed LCD DL40433: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — CGS

Policy LCD-DL40433 · Oncology

High

This proposed LCD from CGS (J15) addresses coverage of transcriptional biomarkers used for therapeutic decision-making in renal carcinoma, applicable to Part A and Part B in Kentucky and Ohio. As a dr

View alert

Audit documentation

Building an audit file that includes LCD-DL40433?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription